Charles Schwab’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-45,825
| Closed | -$67K | – | 3230 |
|
2018
Q1 | $67K | Hold |
45,825
| – | – | ﹤0.01% | 3060 |
|
2017
Q4 | $104K | Hold |
45,825
| – | – | ﹤0.01% | 3031 |
|
2017
Q3 | $156K | Hold |
45,825
| – | – | ﹤0.01% | 3040 |
|
2017
Q2 | $163K | Hold |
45,825
| – | – | ﹤0.01% | 3059 |
|
2017
Q1 | $156K | Hold |
45,825
| – | – | ﹤0.01% | 2965 |
|
2016
Q4 | $211K | Buy |
45,825
+30,700
| +203% | +$141K | ﹤0.01% | 2949 |
|
2016
Q3 | $65K | Hold |
15,125
| – | – | ﹤0.01% | 3021 |
|
2016
Q2 | $37K | Hold |
15,125
| – | – | ﹤0.01% | 3083 |
|
2016
Q1 | $72K | Hold |
15,125
| – | – | ﹤0.01% | 3015 |
|
2015
Q4 | $60K | Hold |
15,125
| – | – | ﹤0.01% | 3064 |
|
2015
Q3 | $59K | Hold |
15,125
| – | – | ﹤0.01% | 3061 |
|
2015
Q2 | $70K | Buy |
+15,125
| New | +$70K | ﹤0.01% | 3064 |
|